Contents
Current Angiogenesis (Discontinued), Volume 1 - Number 4
Endothelial Cell Heterogeneity: A Developmental Biologist’s Perspective
, 1(4): 261 - 265Robert Auerbach and Wanda Auerbach
DOI: 10.2174/2211552811201040261
Incorporation of Anti-angiogenic Therapies in the Treatment of Epithelial Ovarian Cancer: Current Perspectives and Future Directions
, 1(4): 266 - 276Ramez N. Eskander and Philip J. DiSaia
DOI: 10.2174/2211552811201040266
Novel Antitumor Strategies Using Cytokine PEDF for Prostate Cancer Therapy
, 1(4): 277 - 298Olga Zolochevska, Sofia H. Bergstrom, Brennen Comeaux, Todd Emrick and Marxa L. Figueiredo
DOI: 10.2174/2211552811201040277
Intracellular and Extracellular miRNAs in Regulation of Angiogenesis Signaling
, 1(4): 299 - 307Nnenna A. Finn and Charles D. Searles
DOI: 10.2174/2211552811201040299
Toll-like Receptor 4 Regulation of Corneal Angiogenesis
, 1(4): 308 - 317Sharon A. McClellan, Minhao Wu, Yunfan Zhang, Ronald P. Barrett and Linda D. Hazlett
DOI: 10.2174/2211552811201040308
Anti-Angiogenic Treatment for Exudative Age-Related Macular Degeneration: New Strategies are Underway
, 1(4): 318 - 334Patrycja Nowak-Sliwinska
DOI: 10.2174/2211552811201040318
Kinase Inhibitors Targeting Anti-angiogenesis as Anti-cancer Therapies
, 1(4): 335 - 346Jing Liu, Feiyang Liu, David L. Waller, Junfeng Wang and Qingsong Liu
DOI: 10.2174/2211552811201040335
Immunohistochemical Expression of Vascular Endothelial Growth Factor (VEGF) and its Possible Role in Tumour Progression During Malignant Transformation of Atrophic Epithelium in Oral Submucous Fibrosis
, 1(4): 347 - 353Rajiv S. Desai, Mamatha G. S, Musarrat J. Khatri and Subraj J. Shetty
DOI: 10.2174/2211552811201040347
Webmaster Contact: info@benthamscience.net